Utpal Koppikar

Director/Board Member chez C4 THERAPEUTICS, INC.

Fortune : 172 592 $ au 31/03/2024

53 ans

Health Technology

Consumer Services

Postes actifs de Utpal Koppikar

Sociétés	Poste	Début	Fin
C4 THERAPEUTICS, INC.	Director/Board Member	16/03/2022	-
C4 THERAPEUTICS, INC.	Independent Dir/Board Member	16/03/2022	-

Sociétés	Poste	Début	Fin
ATARA BIOTHERAPEUTICS, INC.	Director of Finance/CFO	07/06/2018	31/03/2023
FLEXION THERAPEUTICS, INC.	Director/Board Member	09/07/2021	19/11/2021
GILEAD SCIENCES, INC.	Corporate Officer/Principal	01/02/2017	01/06/2018

Stanford University	Graduate Degree
University of Maryland	Undergraduate Degree
UCLA Anderson School of Management	Masters Business Admin

Internationale

Etats-Unis

Opérationnelle

Sectorielle

Health Technology	5
Consumer Services	4

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	1
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.	Health Technology

Entreprise privées

Health Technology